Our previous work established that knocking down LZK reduced cell viability, proliferation, and colony formation of 3q amplicon-positive HNSCC cells and reduced tumor burden in a xenograft mouse model of HNSCC (1). The gene discussed is MAP3K13; the disease is neoplasm.